Using motivational interviewing to improve outcomes in COPD patients
Official title: Effect of Motivational Interviewing Based on Pender's Health Promotion Model on Patient-Reported Outcomes in Patients With COPD
Run by Ataturk University · NCT06783582 · Data updated 2026-11-12
This study is trying to see if motivational interviewing by nurses can help improve the quality of life for people with COPD who have been in treatment for at least six months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Ataturk University Academic / other |
| Locations | 1 site (Erzurum) |
| Status | Recruiting |
| Started | March 29, 2024 |
| Main results expected | February 24, 2025 |
| Study ends | March 30, 2025 |
| Registry record updated | January 22, 2025 |
| Trial ID | NCT06783582 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with GOLD Stage II or III COPD who have been receiving treatment for more than six months.
✕Probably not a fit
Patients with GOLD Stage I or IV COPD, those experiencing exacerbations, or individuals with serious comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of motivational interviewing based on Pender's health promotion model in enhancing patient-reported outcomes for individuals with Chronic Obstructive Pulmonary Disease (COPD). The intervention focuses on the role of nurses in providing holistic care and support to patients, addressing both physical and psychological challenges associated with COPD. Participants will engage in online interviews to assess the impact of this approach on their quality of life and overall health management. The study targets patients who have been receiving treatment for COPD for at least six months and are in GOLD Stage II or III of the disease.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and health outcomes for patients with COPD.
How similar studies have gone: Previous studies have shown promising results using motivational interviewing in chronic disease management, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being over 18 years of age, * Volunteering to participate in the study, * Being literate, * Having GOLD Stage II and III COPD, * Receiving COPD treatment for more than 6 months, * Having a smartphone for online interviews, * Not having sensory loss related to hearing and vision, * Not having a history of psychiatric diagnosis, * Being suitable for applying cognitive level scales. Exclusion Criteria: * Having GOLD Stage I and IV COPD, * Having serious pulmonary and malignant disease, * Not being able to communicate in Turkish, * Being in an exacerbation period, * Having a history of psychiatric diagnosis.
Where it's running
-
Ataturk University
Erzurum, Turkey (Türkiye) Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
-
Biomarker clues for COPD, IPF, and lung cancer
This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.
-
HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults
This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.